| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
90,000,000 |
| Market
Cap: |
1.70(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.88 - $18.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Latham John A |
Chief Scientific Officer |
• – – |
2015-06-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
|
- |
|
| Schatzman Randall C |
President and CEO |
• • – |
2015-05-26 |
4 |
S |
$38.96 |
$1,948,085 |
D/D |
(50,000) |
109,921 |
|
- |
|
| Schatzman Randall C |
President and CEO |
• • – |
2015-05-26 |
4 |
OE |
$0.39 |
$19,250 |
D/D |
50,000 |
159,921 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-05-22 |
4 |
S |
$38.47 |
$277,027 |
D/D |
(7,202) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-05-22 |
4 |
OE |
$0.06 |
$396 |
D/D |
7,202 |
7,202 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-05-21 |
4 |
S |
$38.92 |
$2,125,496 |
D/D |
(54,616) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-05-21 |
4 |
OE |
$0.06 |
$3,004 |
D/D |
54,616 |
54,616 |
|
- |
|
| Dow Stephen M |
Director |
– • – |
2015-05-21 |
4 |
AS |
$65.69 |
$1,313,846 |
I/I |
(20,000) |
314,203 |
|
- |
|
| Dow Stephen M |
Director |
– • • |
2015-05-20 |
4/A |
S |
$40.39 |
$341,820 |
I/I |
(8,462) |
4,313,992 |
|
- |
|
| Benedict Larry |
Sr. VP Finance |
• – – |
2015-05-19 |
4 |
S |
$38.86 |
$777,196 |
D/D |
(20,000) |
663 |
|
- |
|
| Benedict Larry |
Sr. VP Finance |
• – – |
2015-05-19 |
4 |
OE |
$1.65 |
$33,000 |
D/D |
20,000 |
20,663 |
|
- |
|
| Sevin Rosen Ix Affiliates Fund L.p. |
10% Owner |
– – • |
2015-05-19 |
4 |
S |
$37.02 |
$42,059,899 |
I/I |
(1,136,100) |
4,048,874 |
|
- |
|
| Siegall Clay B |
Director |
– • – |
2015-05-18 |
4 |
S |
$39.97 |
$799,418 |
D/D |
(20,000) |
4,444 |
|
- |
|
| Siegall Clay B |
Director |
– • – |
2015-05-14 |
4 |
S |
$35.04 |
$637,077 |
D/D |
(18,181) |
24,444 |
|
- |
|
| Siegall Clay B |
Director |
– • – |
2015-05-14 |
4 |
OE |
$0.33 |
$6,000 |
D/D |
18,181 |
42,625 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-05-01 |
4 |
AS |
$25.67 |
$100,130 |
D/D |
(3,900) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-05-01 |
4 |
OE |
$0.39 |
$1,502 |
D/D |
3,900 |
3,900 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-05-01 |
4 |
AS |
$25.67 |
$116,663 |
D/D |
(4,545) |
208,988 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-05-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,533 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-04-01 |
4 |
AS |
$27.43 |
$106,995 |
D/D |
(3,900) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-04-01 |
4 |
OE |
$0.39 |
$1,502 |
D/D |
3,900 |
3,900 |
|
- |
|
| Litton Mark James |
Chief Business Officer |
• – – |
2015-04-01 |
4 |
AS |
$27.41 |
$205,553 |
D/D |
(7,500) |
74,359 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-04-01 |
4 |
AS |
$27.42 |
$124,609 |
D/D |
(4,545) |
208,988 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-04-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,533 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-03-30 |
4 |
AS |
$30.20 |
$437,909 |
D/D |
(14,500) |
208,988 |
|
- |
|
296 Records found
|
|
Page 10 of 12 |
|
|
